nf-kappa b - CISMeF

Preferred Label : nf-kappa b;

MeSH definition : Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.;

MeSH synonym : enhancer-binding protein, immunoglobulin; factor nf-kb, transcription; nf-kappab; nuclear factor kappa b; transcription factor nf kb; nf-kb, transcription factor; nf-kb; nf kb; immunoglobulin enhancer-binding protein; immunoglobulin enhancer binding protein; kappa b enhancer binding protein; nf kappab; transcription factor nf-kb; Nuclear Factor-Kappab; Factor-Kappab, Nuclear; Nuclear Factor Kappab;

MeSH hyponym : Ig-EBP-1; Ig EBP 1;

Related MeSH term : Complex, NF-kappa B; NF kappa B Complex;

MeSH annotation : DF: NFKB;

Wikipedia link : https://en.wikipedia.org/wiki/Nf-kappa b;

Is substance : O;

Details

Origin ID

D016328;

UMLS CUI

C0079904;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- NFKB1 wt Allele [NCIt concept]
Indexing information
- 2-benzo(1,3)dioxol-5-yl-N-(2-(benzothiazol-4-yloxymethyl)phenyl)-N-benzylacetamide [MeSH Supplementary Concept]
- 3,11-dihydroxylup-20(29)-en-28-oic acid [MeSH Supplementary Concept]
- 3,5-bis(2-pyridinylmethylidene)-4-piperidone [MeSH Supplementary Concept]
- 3-(4-methylphenylsulfonyl)-2-propenenitrile [MeSH Supplementary Concept]
- 3-hydroxy-4,3',4',5'-tetramethoxychalcone [MeSH Supplementary Concept]
- 4-(3-benzyl-4-(5-(2-fluorophenyl)-ruan-2-ylmethylene)-5-oxo-4,5-dihydropyrazol-1-yl)benzoic acid [MeSH Supplementary Concept]
- 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine [MeSH Supplementary Concept]
- 6,7-dihydroxy-3,4-dihydroisoquinoline [MeSH Supplementary Concept]
- BAY 11-7085 [MeSH Supplementary Concept]
- DSKB-2 compound [MeSH Supplementary Concept]
- I kappa B beta protein [MeSH Supplementary Concept]
- IkappaBgamma protein, human [MeSH Supplementary Concept]
- LC-1 compound [MeSH Supplementary Concept]
- LRRC19 protein, human [MeSH Supplementary Concept]
- LURAP1 protein, human [MeSH Supplementary Concept]
- N-(2,5-bis(trifluoromethyl)phenyl)-5-bromo-2-hydroxybenzamide [MeSH Supplementary Concept]
- N-(4-chloro-2-fluorophenyl)-2-hydroxybenzamide [MeSH Supplementary Concept]
- NF-kappa B kinase [MeSH Supplementary Concept]
- NFKBIL1 protein, human [MeSH Supplementary Concept]
- NKRF protein, human [MeSH Supplementary Concept]
- SN50 peptide [MeSH Supplementary Concept]
- SN52 peptide [MeSH Supplementary Concept]
- Unc5cl protein, mouse [MeSH Supplementary Concept]
- acetylleucyl-leucyl-norleucinal [MeSH Supplementary Concept]
- artemisolide [MeSH Supplementary Concept]
- caffeic acid phenethyl ester [MeSH Supplementary Concept]
- clerodendiod B [MeSH Supplementary Concept]
- embellicine A [MeSH Supplementary Concept]
- eriocalyxin B [MeSH Supplementary Concept]
- isohelenin [MeSH Supplementary Concept]
- isopropyl 4-oxo-4-(2-oxopyrrolidin-1-yl)-2-butenoate [MeSH Supplementary Concept]
- japonicone A [MeSH Supplementary Concept]
- malloapelta B [MeSH Supplementary Concept]
- parthenolide [MeSH Supplementary Concept]
- ponapensin [MeSH Supplementary Concept]
- pyrrolidine dithiocarbamic acid [MeSH Supplementary Concept]
- rheosmin [MeSH Supplementary Concept]
Record concept(s)
- Ig-EBP-1 [MeSH concept]
- NF-kappa B [MeSH concept]
- NF-kappa B Complex [MeSH concept]
Related MeSH Supplementary Concept(s)
- TONSL protein, human [MeSH Supplementary Concept]
- p50B-p97 protein, human [MeSH Supplementary Concept]
See also
- HIV enhancer [MeSH Descriptor]
- i-kappa b proteins [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
UMLS correspondences (same concept)
- NF-kB [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients